C
Curanex Pharmaceuticals Inc (CURX)
NCM – Real Time Price. Currency in USD
0.28
-0.06 (-16.42%)
At close: Jun 18, 2026, 4:00 PM EDT
0.28
+0.00 (1.79%)
After-hours: Jun 18, 2026, 7:54 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.28
-0.06 (-16.42%)
At close: Jun 18, 2026, 4:00 PM EDT
0.28
+0.00 (1.79%)
After-hours: Jun 18, 2026, 7:54 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | N/A | 6.05 | N/A | |
| Quick ratio | N/A | 5.63 | N/A | |
| Debt to Equity | N/A | 0.30 | N/A | |
| Debt to Assets | N/A | 1.04 | N/A | |
| Interest coverage | N/A | -16.91 | N/A | |
| Weighted average score | N/A | |||
| METRIC | TTM |
|---|---|
| Total Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | N/A |
| Net Income | N/A |
| EBITDA | N/A |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | N/A | |
| Operating margin % | N/A | -24.60 | N/A | |
| Net margin % | N/A | -172.20 | N/A | |
| EBITDA margin % | N/A | -201.27 | N/A | |
| Cash flow margin % | N/A | -156.39 | N/A | |
| Weighted average score | N/A | |||
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| ROA | N/A | -57.97 | N/A | |
| ROE | N/A | -63.56 | N/A | |
| ROIC | N/A | -42.57 | N/A | |
| ROCE | N/A | -71.10 | N/A | |
| Weighted average score | N/A | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | N/A |
| Next quarter | N/A | N/A | N/A |
| Current year | N/A | N/A | N/A |
| Next year | N/A | N/A | N/A |
| Weighted average score | N/A | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | N/A | N/A | N/A | N/A | N/A |
| Y/Y | N/A | N/A | N/A | N/A | N/A |
| 3y average | N/A | N/A | N/A | N/A | N/A |
| 5y average | N/A | N/A | N/A | N/A | N/A |
| Weighted average score | N/A | ||||
| NAME | RATIO | INDUSTRY | 5Q TREND | SCORE |
|---|---|---|---|---|
| P/E | N/A | -5.25 | N/A | |
| PEG (5yr expected) | N/A | 0.27 | N/A | |
| P/S | N/A | 64.66 | N/A | |
| P/B | N/A | 2.96 | N/A | |
| Weighted average score | N/A | |||
DCF model data has not been calculated yet.
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Fair Value data has not been calculated yet.
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $0.0 barely cover the upcoming debt maturities $0.0
Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage